Ulcerative Colitis Clinical Trials in Palo Alto, California
7 studies are recruiting for ulcerative colitis in Palo Alto, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Stanford Cancer Institute Palo Alto, Palo Alto, California
- Locations
- 52 in total
- Run by
- National Cancer Institute (NCI)
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ul…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Sutter Health, Palo Alto, California
- Locations
- 24 in total
- Run by
- Mayo Clinic
-
BOOM-IBD2 Pivotal Clinical Trial
Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tail…
- Stage
- Not phased
- Ages
- 18 to 85
- Site
- PAMF (Palo Alto Medical Foundation), Palo Alto, California
- Locations
- 19 in total
- Run by
- Boomerang Medical
-
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated with vedolizumab for…
- Stage
- Phase 3
- Ages
- 2 to 17
- Site
- Stanford Children's Health, Palo Alto, California
- Locations
- 54 in total
- Run by
- Takeda
-
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
The main aim of this study is to learn about medical problems (adverse events) if vedolizumab subcutaneously (SC) is given to a child or teenager with UC or CD for a long time. Other aims are to understand if the long time use of vedolizumab SC has an impact on the time period until hospital visits…
- Stage
- Phase 3
- Ages
- 2 to 17
- Site
- Stanford Children's Health, Palo Alto, California
- Locations
- 54 in total
- Run by
- Takeda
-
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- Stanford University, Palo Alto, California
- Run by
- Stanford University
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
The purpose of this study is to see how a diet that supplements fermented foods effects inflammation and quality of life in patients with mild to moderate Ulcerative Colitis (UC). There is a paucity of research and an enormous need for better understanding of diet and intestinal inflammation. Ferme…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Stanford University, Palo Alto, California
- Run by
- Stanford University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.